Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MMEX: Great play
GOVX: NIH Zika funds being release on 4/7/17?
Way over due but should be a nice chunk of change.
Congrats to GOVX investors.
Link:
https://www.fic.nih.gov/Funding/News/Pages/funding-news-2017-0403.aspx
MMEX: Still building on viral move.
MMEX a text book case on how a stock can go from 0 to 60 on social media now.
MMEX piggybacked off other plays just like BLKG is doing in the last two days.
A lot of money to be made as this investing thread plays out in coming sessions.
Here is some excellent DD on how some stocks are getting their name in the spotlight.
LINK:
https://viralstocks.com/
BLKG: MMEX investors continue loading up.
Since Monday early MMEX investors have been piling in to BLKG for the move north.
Watch how hot BLKG gets in coming sessions.
Link:
http://thelion.com/bin/forum.cgi?sf=blkg
GOVX: Bought more on pending large Fed Zika vax grant.
Thank u.
BLKG: Volume surging now. 50M share day ala MMEX & CEGX.
GOVX: Immune to pumping.
GeoVax has an HIV prevention vax in Phase Two trials & the stock is .06 cents with a $3.2M market cap.
Today, the Feds fully funded the GOVX trials AND is giving them huge support via free National Lab access, which likely amounts to more than the actual monetary award.
In addition, GOVX has another major grant in the pipeline from the Feds for Zika, payable at any time.
Investors here are not going to make their money off the backs of other retail investors via a penny or two pump.
Investors will get the serious dough from Sanofi or Gilead via a buyout that could easily be north of $150M. A 25 bagger for todays buyers.
Makes no difference if anyone on this board buys or sells at this point.
The NIH is the only DD that matters and they just upped their investment in GOVX.
Link:
https://www.geovax.com/component/easyblog/entry/2017/04/03/geovax-awarded-658-000-nih-grant-for-its-hiv-vaccine-program.html?Itemid=101
GOVX: Immune to pumping.
GeoVax has an HIV prevention vax in Phase Two trials & the stock is .06 cents with a $3.2M market cap.
Today, the Feds fully funded the GOVX trials AND is giving them huge support via free National Lab access, which likely amounts to more than the actual monetary award.
In addition, GOVX has another major grant in the pipeline from the Feds for Zika, payable at any time.
Investors here are not going to make their money off the backs of other retail investors via a penny or two pump.
Investors will get the serious dough from Sanofi or Gilead via a buyout that could easily be north of $150M. A 25 bagger for todays buyers.
Makes no difference if anyone on this board buys or sells at this point.
The NIH is the only DD that matters and they just upped their investment in GOVX.
Link:
https://www.geovax.com/component/easyblog/entry/2017/04/03/geovax-awarded-658-000-nih-grant-for-its-hiv-vaccine-program.html?Itemid=101
GOVX: Zika platform at CENTER of NIH $100M trials.
NOTE: The NIH news today concerning the HIV vax effort put GOVX in the top tier of HIV related bio/pharmas
The NIH is also placing a priority on the GOVX DNA based platform for the Zika vax trials that is now kicking into high gear.
My standing advice is to buy 500,000 shares of GOVX and sit back.
If it drops, buy more.
Here is the NIH Zika news:
http://hosted.ap.org/dynamic/stories/U/US_MED_ZIKA_VACCINE?SITE=AP&SECTION=HOME&TEMPLATE=DEFAULT&CTIME=2017-03-31-14-55-50
GeoVax: DNA based Zika vax:
http://www.fiercepharma.com/vaccines/geovax-breaks-into-zika-vaccine-realm-promising-preclinical-data
GOVX: Zika platform at CENTER of NIH $100M trials.
NOTE: The NIH news today concerning the HIV vax effort put GOVX in the top tier of HIV related bio/pharmas
The NIH is also placing a priority on the GOVX based platform for the Zika vax trials that is now kicking into high gear.
My standing advice is to buy 500,000 shares of GOVX and sit back.
If it drops, buy more.
Here is the NIH Zika news:
http://hosted.ap.org/dynamic/stories/U/US_MED_ZIKA_VACCINE?SITE=AP&SECTION=HOME&TEMPLATE=DEFAULT&CTIME=2017-03-31-14-55-50
BLKG: Huge buys starting as MMEX & CEGX crowd piles in.
Easy 500% move here and likely much higher.
Congrats to those holding and other loading up.
GOVX: Total Fed Zika & HIV $$ = 33% of current market cap.
The pending Fed Zika $$ grant will be substantial in comparison to the current GOVX market cap.
Adding that to todays news gives confidence to GOVX share holders going forward.
In addition, pharma giants like Sanofi & Gilead now have the the nod form the Feds in regard to the value of the GOVX platform.
At some point GOVX is a goner at any time.
When it happens, it happens.
Holding GOVX is a longterm winner and likely a shor term lotto play multi-multi-bag winner.
Congrats to those that have held and added over the last few months.
Link:
https://biobridgeglobal.org/zika
BLKG: Heads up. MMEX & CEGX crowd on BLKG now. Sending over .01
Watch how they mob BLKG all week.
Easy target for them to move north.
Congrats & buy more if you can right now.
GOVX: Buy 500,000 @ .06. Sell 500,00 @ $1.00+..= $500,000+
The Feds just told the market that GOVX is a world class AIDS vax company.
The share count is less than many top tier Nasdaq bio/pharmas trading @ 8 figure market caps.
Buying 500,000 shares now is quite sensible and prudent.
The Feds just removed any doubt about GOVX.
GOVX @ .06: In line for large Zika grant. Cash due now.
The Fed Zika cash started flowing recently.
Some States have already received funds.
At some point, maybe later today, for all we know, GOVX is going to get hot.
In the meantime, it has been a great time to lay low and pick up shares on the cheap.
Load up and sit back. GOBVX on auto-pilot now.
Link: Zika funding.
http://www.pharmpro.com/news/2016/04/geovax-seeks-funding-speed-zika-vaccine-program
GOVX: Grant = 20% current market cap. Large Zika grant also due
At some point GOVX will get scooped up for serious cash. Over $100M, imo.
Bio/pharma giant Sanofi the likely buyer.
GOVX @ .06: Awarded $658,000 HIV grant via NIH
Roughly 20% of market cap.
In addition, Zika grant is also due.
GOVX a low floater (in regard to otcbb).
Imo, the single biggest bang for the buck in bio/pharma right now.
Link:
http://finance.yahoo.com/news/geovax-awarded-658-000-nih-130000118.html
GOVX @ .06: $658,000 HIV grant via NIH:
Roughly 20% of market cap.
In addition, Zika grant is also due.
GOVX a low floater (in regard to otcbb).
Imo, the single biggest bang for the buck in bio/pharma right now.
Link:
http://finance.yahoo.com/news/geovax-awarded-658-000-nih-130000118.html
LENS @ $3.14: Micro-float crowd will find it. Stocktwits rising.
Was too late in the week when it got noticed to move it last week.
Well worth watching now.
GALT: Other NASH play BLRX @ .90s.
BioLineRX did a $25M secondary today that sent the stock to .90s.
The great move in GALT is a set-up for BLRX now that the secondary is out of the way and BLRX is flush.
Novartis is the BLRX partner on the NASH liver drug.
Link:
http://www.fiercebiotech.com/biotech/novartis-partner-biolinerx-licenses-nash-drug-after-joint-evaluation
GALT: Other NASH play BLRX @ .90s.
BioLineRX did a $25M secondary today that sent the stock to .90s.
The great move in GALT is a set-up for BLRX now that the secondary is out of the way and BLRX is flush.
Novartis is the BLRX partner on the NASH liver drug.
Link:
http://www.fiercebiotech.com/biotech/novartis-partner-biolinerx-licenses-nash-drug-after-joint-evaluation
LENS @ $3.18: Low float crowd will launch it.
Watching numbers on StockTwits rising.
Posts on message aggregating boards rising.
Almost always a good indicator of where the low float launch crew is headed next.
Website:
https://presbia.com/
LENS @ $3.18: Low float crowd will launch it.
Watching numbers on StockTwits rising.
Posts on message aggregating boards rising.
Almost always a good indicator of where the low float launch crew is headed next.
Website:
https://presbia.com/
MRLA @ .22: Algo detects skin cancer from any phone. Low floater.
FaceBook"s Zuckerberg said it is a top Artificial Intelligence company.
MRLA getting global attention lately.
Big play.
Link:
http://www.dermacompare.com/
MRLA @ .22: Algo detects skin cancer from any phone. Low floater.
FaceBook"s Zuckerberg said it is a top Artificial Intelligence company.
MRLA getting global attention lately.
Big play.
Link:
http://www.dermacompare.com/
LENS @ 3.20s: Lo float crowd that sent BIOP on Weds on it now.
Same set-up. same likely move over $4.00.
LENS @ 3.20s: Lo float crowd that sent BIOP yesterday on it.
Same set-up. same likely move over $4.00.
CRTN: After today, $4.00 by Q1, 2017 news on 4/17
Positive 10-K due in 30 minutes.
Killer Q1, 2017 in 6 weeks.
Load up.
CRTN @ $1.14:...10-K in 60 mins.
STAF @ .80: Turned down $1.10 a share buyout.
The stock popped on the buyout news and then pooped on the turn down by management,
Highly likely that the bidder ups the offer over $1.10 or another buyer steps in at higher price.
In any event, STAF InPlay & well worth doing some DD before the next buyout offer.
Link:
http://finance.yahoo.com/news/staffing-360-solutions-board-directors-211606112.html
OVAS: Lawsuit filed 3/24
Looks like ambulance chasing crew but still is not good news.
http://www.prnewswire.com/news-releases/lifshitz--miller-llp-files-class-action-lawsuit-against-ovascience-inc-300429943.html
NOTE: MRLA @ .21 Low float: The # 1 artificial intelligence play right now. Detects skin cancer via smartphone algo better than doctor. Mark Zuckerberg on it.
Website:
MRLA @ .21: Detect skin cancer via phone algo. Great AI stock.
MRLA one of the big plays in Artificial Intelligence stocks.
One of the greats. Low floater too.
Link:
https://www.newswire.com/news/zuckerberg-marks-artificial-intelligence-as-next-wave-of-healthcare-10744388
MRLA @ .21: Mark Zuckerberg on it. Detect skin cancer via phone algo.
MRLA one of the big plays in Artificial Intelligence stocks.
One of the greats. Low floater too.
Link:
https://www.newswire.com/news/zuckerberg-marks-artificial-intelligence-as-next-wave-of-healthcare-10744388
CRTN @ $ 1.08 ahead of strong 10-K
CRTN was pointed out on this board @ .50s a number of months ago.
Price is up 100% +
The DD points to strong positive news Weds. @ 4:30pm and further movement north.
CRTN is a low floater and will be seen as quite a bargain after Weds.
By then the $1.08s will be gone, of course
Recent news;
http://ir.cartesian.com/phoenix.zhtml?c=110509&p=irol-newsArticle&ID=2238744
NOTE: MRLA @ .22 also well worth doing some serious DD. That is a big play. Algo detects skin cancer via smartphone
CRTN @ 1.08: Sterling 10-K due Weds. Lo float & serious profit.
Imo, CRTN is going to see some serious buying in next few days to place it right near recent highs for the Weds @ 4:30PM 10-K release.
CRTN has all but told us to expect a stronng Q4 & full year 2016 Report. Add in positive forward guidance and CRTN will be popping very nicely in coming sessions.
NOTE: It helps that CRTN is a media play and not a bio/pharma in this unsteady climate.
Website:
http://www.cartesian.com/
SA article:
https://seekingalpha.com/article/3813036-cartesian-shifting-business-models-accretive-acquisitions-equals-high-probable-upside
CRTN @ 1.08: Positive Q due Weds. ONLY profitabe Nas play under $4.
Nuts. But that is ok.
Loaded up here the last few days.
Sterling numbers due 3/29 after close.
Website:
http://www.cartesian.com/
CRTN @ 1.08: Positive Q due Weds. ONLY profitabe Nas play under $4.
Nuts. But that is ok.
Loaded up here the last few days.
Sterling numbers due 3/29 after close.
Website:
http://www.cartesian.com/
MRLA @ .22: Lo float. Melanoma detected via phone app. Big backers now.
MRLA just closed a private placement in Israel for .40 a share that went unnoticed in USA.
MRLA starting to get gloabal attention, including Zuckerberg talking about the tech in a recent speech, without mentioning the MRLA company name.
Do your DD.
Great science. Big names involved and full support of the Israeli governments medical agencies.
Big one
FaceBook: Zuckerberg:
https://www.accesswire.com/439481/Zuckerberg-Marks-Artificial-Intelligence-as-Next-Wave-of-Healthcare-Reports-Emerald-Medical-Applications-Corp
MRLA DermaCompare website:
http://www.dermacompare.com/
MRLA @ .22: FaceBook"s Jeff Zuckerberg on it. Melanoma detect via phone app.
MRLA just closed a private placement in Israel for .40 a share that went unnoticed in USA.
MRLA starting to get gloabal attention, including Zuckerberg talking about the tech in a recent speech, without mentioning the MRLA company name.
Do your DD.
Great science. Big names involved and full support of the Israeli governments medical agencies.
Big one
FaceBook: Zuckerberg:
https://www.accesswire.com/439481/Zuckerberg-Marks-Artificial-Intelligence-as-Next-Wave-of-Healthcare-Reports-Emerald-Medical-Applications-Corp
MRLA DermaCompare website:
http://www.dermacompare.com/